BY OUR PLATFORMS
BY THERAPEUTIC AREA
Carles Cornet - 11 May 2022
Why zebrafish can pave the way for investigating epilepsy’s etiology and screening new anti-seizure drugs
Flavia de Santis - 10 February 2021
ZeClinics can do it by using different genome editing approaches.
Vincenzo Di Donato - 13 January 2021
ZeClinics laboratory R&D efforts are mainly divided in the development of three research platforms including a number of research areas.